MedTrace Logo

Bladder Cancer Patient-Reported Outcomes

NCT01090388 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2016-11-09

No results posted yet for this study

Summary

The purpose of this study is to identify aspects of the bladder cancer (BlCa) survivorship experience that differ by clinical risk at diagnosis. The investigators will collect cross-sectional data from persons with BlCa to identify aspects of health-related quality of life (HRQOL) and symptom management. The study originally enrolled only nonmuscle-invasive bladder cancer survivors but has been expanded to include survivors with any stage disease. Information from this study will be used to develop a new patient education and counseling intervention.

Conditions

  • Bladder Neoplasms

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • David M Latini, PhD · Baylor College of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2011-08-31
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090388 on ClinicalTrials.gov